---
name: stagemigration
title: Advanced TNM Stage Migration Analysis
menuGroup: OncoPath
menuSubgroup: Stage Migration Analysis
menuSubtitle: 'State-of-the-Art Staging System Validation'
version: '0.0.31'
jas: '1.2'

description:
    main: >-
      Comprehensive analysis for validating TNM staging system improvements using state-of-the-art 
      statistical methods. This analysis provides pathologists with robust tools to evaluate whether 
      a new staging system provides superior prognostic discrimination compared to existing systems.
      
      Includes advanced metrics: Net Reclassification Improvement (NRI), Integrated Discrimination 
      Improvement (IDI), time-dependent ROC analysis, decision curve analysis, bootstrap validation, 
      and comprehensive clinical interpretation guidance.
    R:
        dontrun: true
        usage: |
            # Example analyzing TNM staging system migration:
            # stagemigration(
            #   data = cancer_cohort,
            #   oldStage = "tnm7_stage", 
            #   newStage = "tnm8_stage",
            #   survivalTime = "os_months",
            #   event = "death_status",
            #   eventLevel = "Dead",
            #   analysisType = "comprehensive",
            #   calculateNRI = TRUE,
            #   calculateIDI = TRUE,
            #   performBootstrap = TRUE,
            #   bootstrapReps = 1000
            # )

options:
    - name: data
      type: Data
      description:
          R: >
            The dataset containing staging and survival information for TNM validation analysis.

    # Core Variables (Enhanced with Clinical Examples)
    - name: oldStage
      title: 'Original TNM Staging System'
      type: Variable
      suggested: [ordinal, nominal]
      permitted: [factor]
      description: >-
        ðŸ“‹ CLINICAL EXAMPLE: Select your current staging variable such as 'TNM7_Stage' 
        containing values like: Stage I, Stage IIA, Stage IIB, Stage IIIA, Stage IIIB, Stage IV.
        
        ðŸ” TECHNICAL DETAILS: The original staging variable (e.g., TNM 7th edition, AJCC 7th edition).
        Should be coded as ordered factor with appropriate stage levels for meaningful comparison.

    - name: newStage
      title: 'New/Revised TNM Staging System'
      type: Variable
      suggested: [ordinal, nominal]
      permitted: [factor]
      description: >-
        ðŸ“‹ CLINICAL EXAMPLE: Select your new staging variable such as 'TNM8_Stage' 
        containing the same patients but potentially different stage assignments based on 
        revised criteria (e.g., T descriptor changes, nodal assessment updates).
        
        ðŸ” TECHNICAL DETAILS: The proposed new staging variable (e.g., TNM 8th edition, revised staging).
        Should use the same coding structure as the original staging system for valid comparison.

    - name: survivalTime
      title: 'Follow-up Time (months)'
      type: Variable
      suggested: [continuous]
      permitted: [numeric]
      description: >-
        ðŸ“‹ CLINICAL EXAMPLE: Select your follow-up time variable such as 'OS_months' 
        containing values like: 12.5, 24.8, 36.2, 45.0 (months from diagnosis to death or last contact).
        
        ðŸ” TECHNICAL DETAILS: Time to event or censoring in consistent units (months recommended).
        For overall survival analysis, use time from diagnosis to death or last follow-up.
        For disease-free survival, use time from treatment to recurrence or last follow-up.

    - name: event
      title: 'Event Status (Death/Outcome)'
      type: Variable
      suggested: [ordinal, nominal, continuous]
      permitted: [factor, numeric]
      description: >-
        ðŸ“‹ CLINICAL EXAMPLE: Select your event variable such as 'Death_Status' 
        containing values like: 0 (alive/censored), 1 (dead/event occurred) OR 
        "Alive", "Dead" OR "No Event", "Death", "Disease Progression".
        
        ðŸ” TECHNICAL DETAILS: Event indicator (1 = event occurred, 0 = censored) or factor with event levels.
        For overall survival, event = death from any cause. For disease-specific survival, 
        event = death from the specific disease being studied.

    - name: eventLevel
      title: Event Level
      type: Level
      variable: (event)
      description: >-
        The level indicating event occurrence when using factor variables.

    # Clinical Analysis Presets (New Feature)
    - name: clinicalPreset
      title: 'Clinical Analysis Preset'
      type: List
      options:
        - title: "ðŸ¥ Routine Clinical Validation (Basic + Key Metrics)"
          name: routine_clinical
        - title: "ðŸ“Š Research Study (Standard + Advanced Statistics)"  
          name: research_study
        - title: "ðŸ“ Publication Manuscript (All Methods + Visualizations)"
          name: publication_ready
        - title: "ðŸ”¬ Custom Analysis (Manual Configuration)"
          name: custom
      default: routine_clinical
      description: >-
        Choose a preset tailored to your clinical workflow. 'Routine Clinical' provides essential 
        validation metrics for daily practice. 'Research Study' adds advanced statistics for 
        academic research. 'Publication Ready' includes all methods and visualizations for manuscripts.
        Choose 'Custom' to manually configure all options.

    - name: enableGuidedMode
      title: 'ðŸ§­ Guided Analysis Mode'
      type: Bool
      default: true
      description: >-
        Enable step-by-step guidance for clinical users. Provides contextual help, 
        assumption checking, and clinical interpretation assistance throughout the analysis.
        Highly recommended for users new to staging validation methods.

    - name: generateCopyReadyReport
      title: 'ðŸ“„ Generate Copy-Ready Clinical Summary'
      type: Bool
      default: true
      description: >-
        Generate plain-language clinical summary paragraphs that can be copied directly 
        into reports or manuscripts. Includes key findings, statistical significance, 
        clinical interpretation, and implementation recommendations.

    # Accessibility and User Experience Options
    - name: enableAccessibilityFeatures
      title: 'â™¿ Accessibility Features'
      type: Bool
      default: false
      description: >-
        Enable accessibility features including color-blind safe palettes, 
        high contrast visualizations, larger font sizes, and enhanced table readability.
        Ensures outputs are accessible to users with visual impairments.

    - name: preferredLanguage
      title: 'ðŸŒ Output Language'
      type: List
      options:
        - title: "English (EN)"
          name: en
        - title: "TÃ¼rkÃ§e (TR)"
          name: tr
      default: en
      description: >-
        Choose the language for explanations, labels, and clinical interpretations.
        Scientific terminology and statistical results remain standardized.

    - name: enableProgressIndicators
      title: 'â±ï¸ Show Progress Indicators'
      type: Bool
      default: true
      description: >-
        Show progress bars and status updates for long-running analyses such as 
        bootstrap validation and cross-validation. Helps users track analysis progress.

    - name: optimizeForLargeDatasets
      title: 'ðŸš€ Large Dataset Optimization'
      type: Bool
      default: false
      description: >-
        Enable memory-efficient processing for large datasets (>10,000 patients). 
        Uses chunked processing and optimized algorithms to reduce memory usage 
        and improve performance while maintaining statistical accuracy.

    # Analysis Type and Core Options  
    - name: analysisType
      title: 'Analysis Scope'
      type: List
      options:
        - title: "Basic Migration Analysis"
          name: basic
        - title: "Standard Validation (includes C-index, NRI)"
          name: standard  
        - title: "Comprehensive Analysis (all methods)"
          name: comprehensive
        - title: "Publication Ready (optimized for manuscripts)"
          name: publication
      default: comprehensive
      description: >-
        Determines the scope of statistical analysis performed. Comprehensive analysis
        includes all available methods for thorough staging system validation.

    - name: confidenceLevel
      title: 'Confidence Level'
      type: Number
      min: 0.80
      max: 0.99
      default: 0.95
      description: >-
        Confidence level for all confidence intervals and hypothesis tests.

    # Advanced Statistical Methods
    - name: calculateNRI
      title: 'Net Reclassification Improvement (NRI)'
      type: Bool
      default: false
      description: >-
        Calculate Net Reclassification Improvement to quantify improvement in 
        risk classification between staging systems. Essential for staging validation.

    - name: nriTimePoints
      title: 'NRI Time Points (months)'
      type: String
      default: "12, 24, 60"
      description: >-
        Comma-separated time points for NRI calculation (e.g., "12, 24, 60" for 
        1, 2, and 5-year survival). Use clinically relevant time points.

    - name: calculateIDI
      title: 'Integrated Discrimination Improvement (IDI)'
      type: Bool
      default: false
      description: >-
        Calculate Integrated Discrimination Improvement to measure improvement 
        in risk prediction accuracy between staging systems.

    - name: performROCAnalysis
      title: 'Time-dependent ROC Analysis'
      type: Bool
      default: false
      description: >-
        Perform time-dependent ROC analysis to compare discriminative ability
        of staging systems over time.

    - name: rocTimePoints
      title: 'ROC Time Points (months)'
      type: String
      default: "12, 24, 36, 60"
      description: >-
        Time points for ROC analysis. Should include clinically important
        survival milestones for the specific cancer type.

    - name: performDCA
      title: 'Decision Curve Analysis'
      type: Bool
      default: false
      description: >-
        Perform Decision Curve Analysis to assess clinical utility and net benefit
        of the new staging system for clinical decision making.

    - name: performCalibration
      title: 'Calibration Analysis'
      type: Bool
      default: false
      description: >-
        Assess calibration of risk predictions from both staging systems.
        Important for validating accuracy of survival predictions.

    # Validation and Bootstrap Options
    - name: performBootstrap
      title: 'Bootstrap Validation'
      type: Bool
      default: false
      description: >-
        Perform bootstrap validation with optimism correction to assess
        internal validity of results. Recommended for all staging validation studies.

    - name: bootstrapReps
      title: 'Bootstrap Repetitions'
      type: Number
      min: 100
      max: 2000
      default: 1000
      description: >-
        Number of bootstrap repetitions for internal validation. 
        1000 repetitions recommended for stable results.

    - name: performCrossValidation
      title: 'Cross-Validation'
      type: Bool
      default: false
      description: >-
        Perform k-fold cross-validation for additional validation.
        Computationally intensive but provides robust validation.

    - name: cvFolds
      title: 'CV Folds'
      type: Number
      min: 3
      max: 10
      default: 5
      description: >-
        Number of folds for cross-validation when enabled.

    - name: institutionVariable
      title: 'Institution Variable'
      type: Variable
      suggested:
        - nominal
        - ordinal
      permitted:
        - factor
        - numeric
      description: >-
        Optional variable indicating institution or study center for 
        multi-institutional validation. When provided, performs internal-external
        cross-validation using k-1 centers for development and remaining center
        for validation. Essential for multi-center staging validation studies.

    # Clinical Significance Options
    - name: clinicalSignificanceThreshold
      title: 'Clinical Significance Threshold'
      type: Number
      min: 0.01
      max: 0.10
      default: 0.02
      description: >-
        Minimum improvement in C-index considered clinically significant.
        Default 0.02 based on oncology literature recommendations.

    - name: nriClinicalThreshold
      title: 'NRI Clinical Threshold'
      type: Number
      min: 0.10
      max: 0.50
      default: 0.20
      description: >-
        Minimum NRI improvement considered clinically meaningful.
        Default 0.20 (20% net reclassification improvement).

    # Homogeneity and Trend Tests
    - name: performHomogeneityTests
      title: 'Stage Homogeneity Tests'
      type: Bool
      default: false
      description: >-
        Test homogeneity within stages and monotonic trend across stages.
        Essential for validating stage ordering and grouping.

    - name: performTrendTests
      title: 'Stage Trend Analysis'
      type: Bool
      default: false
      description: >-
        Test for monotonic trend in survival across stage levels.
        Validates that higher stages consistently have worse prognosis.

    # Advanced Model Comparison
    - name: performLikelihoodTests
      title: 'Likelihood Ratio Tests'
      type: Bool
      default: false
      description: >-
        Perform formal likelihood ratio tests comparing nested staging models.
        Provides statistical significance testing for staging improvement.

    - name: calculatePseudoR2
      title: 'Pseudo R-squared Measures'
      type: Bool
      default: true
      description: >-
        Calculate multiple pseudo R-squared measures for model comparison
        (Nagelkerke, McFadden, Cox-Snell).

    # Table Display Options
    - name: showMigrationOverview
      title: 'Migration Overview Table'
      type: Bool
      default: true
      description: >-
        Display overview table showing the fundamental migration statistics including:
        total number of patients, number and percentage of patients who migrated stages,
        direction of migration (upstaged vs downstaged), and net migration effect.
        This is the essential first table for understanding the overall impact of the
        new staging system.

    - name: showMigrationSummary
      title: 'Migration Summary Table'
      type: Bool
      default: true
      description: >-
        Display statistical summary of migration patterns including overall migration
        rate and formal statistical tests. Shows Chi-square test results for
        independence and Fisher's exact test p-values to determine if the migration
        patterns are statistically significant. Essential for validating whether
        observed changes are due to genuine staging improvements or random variation.

    - name: showStageDistribution
      title: 'Stage Distribution Comparison Table'
      type: Bool
      default: true
      description: >-
        Display side-by-side comparison of how patients are distributed across stages
        in both the original and new staging systems. Shows the count and percentage
        of patients in each stage, along with the net change. This helps identify
        which stages are gaining or losing patients and whether the new system
        creates better separation between prognostic groups.

    - name: showMigrationMatrix
      title: 'Migration Matrix Table'
      type: Bool
      default: true
      description: >-
        Display detailed cross-tabulation matrix showing exactly how patients moved
        between stages. Rows represent the original staging system and columns represent
        the new staging system. Diagonal values indicate patients who remained in the
        same stage, while off-diagonal values show stage migrations. This is essential
        for understanding the specific migration patterns and identifying which stages
        are most affected by the new criteria.

    - name: showStatisticalComparison
      title: 'Statistical Comparison Table'
      type: Bool
      default: true
      description: >-
        Display table with C-index comparisons and other statistical metrics.

    - name: showConcordanceComparison
      title: 'Concordance Comparison Table'
      type: Bool
      default: true
      description: >-
        Display detailed concordance comparison between staging systems.

    # Visualization Options
    - name: showMigrationHeatmap
      title: 'Migration Heatmap'
      type: Bool
      default: false
      description: >-
        Display a color-coded heatmap visualization of the migration matrix. 
        Darker colors indicate more patients, with the diagonal showing patients 
        who remained in the same stage. This visual representation makes it easy 
        to identify migration patterns at a glance - upstaging appears above the 
        diagonal, downstaging below. Essential for presentations and publications.

    - name: showSankeyDiagram
      title: 'Stage Migration Flow Diagram'
      type: Bool
      default: false
      description: >-
        Display a Sankey flow diagram showing patient migration patterns between 
        original and new staging systems. Flow thickness represents the number of 
        patients moving between stages, making it easy to visualize dominant 
        migration patterns. Excellent for presentations and understanding the 
        overall reclassification impact.

    - name: showROCComparison
      title: 'ROC Curve Comparison'
      type: Bool
      default: false
      description: >-
        Display time-dependent ROC curves comparing staging systems.

    - name: showCalibrationPlots
      title: 'Calibration Plots'
      type: Bool
      default: false
      description: >-
        Display calibration plots for both staging systems.

    - name: showDecisionCurves
      title: 'Decision Curves'
      type: Bool
      default: false
      description: >-
        Display decision curves showing net benefit of staging systems.

    - name: showForestPlot
      title: 'Hazard Ratio Forest Plot'
      type: Bool
      default: false
      description: >-
        Display forest plot with stage-specific hazard ratios and confidence intervals.

    - name: showWillRogersAnalysis
      title: 'Will Rogers Phenomenon Analysis'
      type: Bool
      default: false
      description: >-
        Detailed analysis of Will Rogers phenomenon with survival comparisons
        between migrated and non-migrated patients within stages.

    - name: showWillRogersVisualization
      title: 'Will Rogers Effect Visualization'
      type: Bool
      default: false
      description: >-
        Display visualization showing how stage migration affects survival
        within each stage. Shows before/after survival curves demonstrating
        the Will Rogers paradox where both stages appear to improve.

    - name: showMigrationSurvivalComparison
      title: 'Migration Survival Curve Comparison'
      type: Bool
      default: false
      description: >-
        Display Kaplan-Meier survival curves comparing the same stages before 
        and after patient migration. Shows how survival curves change when 
        patients are reclassified between staging systems, providing visual 
        evidence of the Will Rogers phenomenon and staging system improvements.

    # Survival Plot Options
    - name: showSurvivalCurves
      title: 'Show Survival Curves'
      type: Bool
      default: false
      description: >-
        Display survival curves comparing the staging systems.
    
    - name: survivalPlotType
      title: 'Survival Plot Display'
      type: List
      options:
        - title: "Separate plots for each system"
          name: separate
        - title: "Side-by-side comparison"
          name: sidebyside
        - title: "Overlay comparison"
          name: overlay
      default: separate
      description: >-
        Controls display of survival curves for staging system comparison.

    - name: showConfidenceIntervals
      title: 'Show Confidence Intervals'
      type: Bool
      default: false
      description: >-
        Display confidence intervals around survival curves and other estimates.

    - name: showRiskTables
      title: 'Show Risk Tables'
      type: Bool
      default: false
      description: >-
        Display at-risk tables below survival curves.

    - name: plotTimeRange
      title: 'Plot Time Range (months)'
      type: String
      default: "auto"
      description: >-
        Maximum time for survival plots. Use "auto" for automatic range or
        specify maximum months (e.g., "60" for 5-year follow-up).

    # Output and Reporting Options
    - name: showClinicalInterpretation
      title: 'Clinical Interpretation Guide'
      type: Bool
      default: false
      description: >-
        Display comprehensive clinical interpretation of all statistical results
        with guidance for staging system adoption decisions.

    - name: showStatisticalSummary
      title: 'Statistical Summary Table'
      type: Bool
      default: false
      description: >-
        Display comprehensive table summarizing all statistical comparisons.

    - name: showMethodologyNotes
      title: 'Methodology Notes'
      type: Bool
      default: false
      description: >-
        Display detailed notes on statistical methods used and their interpretation.

    - name: includeEffectSizes
      title: 'Include Effect Sizes'
      type: Bool
      default: false
      description: >-
        Calculate and display effect sizes for all comparisons to assess
        practical significance beyond statistical significance.

    - name: advancedMigrationAnalysis
      title: 'Advanced Migration Analysis'
      type: Bool
      default: false
      description: >-
        Perform comprehensive stage migration analysis including monotonicity 
        checks, Will Rogers phenomenon detection, stage-specific validation, 
        and enhanced discrimination metrics. Provides detailed assessment of 
        staging system quality and migration patterns.

    - name: generateExecutiveSummary
      title: 'Executive Summary'
      type: Bool
      default: false
      description: >-
        Generate executive summary with key findings and recommendations
        for clinical and research stakeholders.

    # Advanced Options for Specific Cancer Types
    - name: cancerType
      title: 'Cancer Type (Optional)'
      type: List
      options:
        - title: "General (use default thresholds)"
          name: general
        - title: "Lung Cancer"
          name: lung
        - title: "Breast Cancer" 
          name: breast
        - title: "Colorectal Cancer"
          name: colorectal
        - title: "Prostate Cancer"
          name: prostate
        - title: "Head and Neck Cancer"
          name: headneck
        - title: "Melanoma"
          name: melanoma
        - title: "Other Solid Tumor"
          name: other
      default: general
      description: >-
        Optional cancer type specification for customized thresholds and 
        interpretation guidelines based on cancer-specific literature.

    - name: useOptimismCorrection
      title: 'Apply Optimism Correction'
      type: Bool
      default: false
      description: >-
        Apply optimism correction to performance metrics using bootstrap
        validation to avoid overly optimistic estimates.

    # Multifactorial Analysis Options
    - name: enableMultifactorialAnalysis
      title: 'Enable Multifactorial Analysis'
      type: Bool
      default: false
      description: >-
        Enable advanced multifactorial stage migration analysis that includes
        additional covariates in the comparison. This allows for adjusted
        comparisons between staging systems after accounting for other
        prognostic factors.

    - name: continuousCovariates
      title: 'Continuous Covariates'
      type: Variables
      suggested: [continuous]
      permitted: [numeric]
      description: >-
        Continuous variables to include as covariates in the multifactorial
        analysis (e.g., age, tumor size, biomarker levels). These will be
        included in Cox regression models for both staging systems.
      default: NULL

    - name: categoricalCovariates
      title: 'Categorical Covariates'
      type: Variables
      suggested: [ordinal, nominal]
      permitted: [factor]
      description: >-
        Categorical variables to include as covariates in the multifactorial
        analysis (e.g., sex, histology, treatment type). These will be
        included in Cox regression models for both staging systems.
      default: NULL

    - name: multifactorialComparisonType
      title: 'Multifactorial Comparison Type'
      type: List
      options:
        - title: "Adjusted C-index comparison"
          name: adjusted_cindex
        - title: "Nested model comparison"
          name: nested_models
        - title: "Stepwise model selection"
          name: stepwise
        - title: "Comprehensive comparison"
          name: comprehensive
      default: comprehensive
      description: >-
        Type of multifactorial comparison to perform. Comprehensive includes
        all methods for thorough evaluation of staging systems in the context
        of other prognostic factors.

    - name: baselineModel
      title: 'Baseline Model'
      type: List
      options:
        - title: "Covariates only"
          name: covariates_only
        - title: "Original staging + covariates"
          name: original_plus_covariates
        - title: "New staging + covariates"
          name: new_plus_covariates
      default: covariates_only
      description: >-
        Baseline model for multifactorial comparisons. This determines the
        reference model against which staging systems are compared.

    - name: performInteractionTests
      title: 'Test Stage-Covariate Interactions'
      type: Bool
      default: false
      description: >-
        Test for interactions between staging systems and covariates. This
        helps identify if the staging system performance varies across
        different patient subgroups.

    - name: stratifiedAnalysis
      title: 'Stratified Analysis'
      type: Bool
      default: false
      description: >-
        Perform stratified analysis by categorical covariates to evaluate
        staging system performance within subgroups.

    - name: showMultifactorialTables
      title: 'Show Multifactorial Tables'
      type: Bool
      default: false
      description: >-
        Display detailed tables showing multifactorial model results,
        including adjusted hazard ratios and model comparison statistics.

    - name: showAdjustedCIndexComparison
      title: 'Show Adjusted C-index Comparison'
      type: Bool
      default: false
      description: >-
        Display comparison of C-indices for staging systems adjusted for
        covariates. This shows the discriminative ability of each staging
        system after accounting for other prognostic factors.

    - name: showNestedModelTests
      title: 'Show Nested Model Tests'
      type: Bool
      default: false
      description: >-
        Display likelihood ratio tests comparing nested models to formally
        test the added value of each staging system over the baseline model.

    - name: showStepwiseResults
      title: 'Show Stepwise Selection Results'
      type: Bool
      default: false
      description: >-
        Display results of stepwise model selection showing which variables
        (including staging systems) are selected in the final model.

    - name: showExplanations
      title: 'Explanations for Results'
      type: Bool
      default: true
      description: >-
        Include detailed explanations for results.

    - name: showAbbreviationGlossary
      title: 'Show Abbreviation Glossary'
      type: Bool
      default: false
      description: >-
        Display a comprehensive glossary of all abbreviations, statistical terms, 
        and technical terminology used in the stage migration analysis. This 
        provides a quick reference for interpreting dashboard values and 
        understanding statistical outputs.

    # Stage Migration Effect Options
    - name: calculateSME
      title: 'Calculate Stage Migration Effect'
      type: Bool
      default: false
      description: >-
        Calculate Stage Migration Effect Formula (SME) to quantify the cumulative 
        difference in survival between corresponding stages of old and new staging 
        systems. SME = Î£(S_new_i - S_old_i) where S represents stage-specific 
        survival rates. Positive values indicate Will Rogers phenomenon (apparent 
        improvement in new system), while negative values suggest understaging.

    # RMST Analysis Options
    - name: calculateRMST
      title: 'Calculate RMST Metrics'
      type: Bool
      default: false
      description: >-
        Calculate Restricted Mean Survival Time (RMST) metrics for robust 
        discrimination assessment. RMST provides clinically interpretable 
        survival measures that are independent of proportional hazards assumptions. 
        Particularly valuable when median survival is not reached or when comparing 
        absolute survival benefits between staging systems.

    # Competing Risks Analysis Options
    - name: performCompetingRisks
      title: 'Perform Competing Risks Analysis'
      type: Bool
      default: false
      description: >-
        Perform competing risks analysis for scenarios with multiple event types 
        (e.g., cancer-specific death vs. other causes). Implements Fine-Gray 
        subdistribution hazard models and Cumulative Incidence Function (CIF) 
        analysis. Essential when competing events prevent observation of primary 
        outcome and standard survival analysis may be biased.

    - name: competingEventVar
      title: 'Competing Event Variable'
      type: Variable
      suggested:
        - nominal
        - ordinal
      permitted:
        - factor
        - numeric
      description: >-
        Optional variable indicating competing events (events other than primary 
        outcome). If not specified, the analysis will attempt to detect competing 
        risks from multi-level event variables. For cancer studies, this typically 
        represents non-cancer deaths when primary outcome is cancer-specific death.

    # Optimal Cut-point Determination Options
    - name: performOptimalCutpoint
      title: 'Optimal Cut-point Determination'
      type: Bool
      default: false
      description: >-
        Determine optimal cut-points for continuous variables that create the most 
        statistically significant separation in survival outcomes. Uses maximal 
        selected rank statistics with appropriate multiple testing corrections. 
        Essential for developing new staging criteria from continuous biomarkers 
        or measurements.

    - name: continuousStageVariable
      title: 'Continuous Variable for Cut-point Analysis'
      type: Variable
      suggested: [continuous]
      permitted: [numeric]
      description: >-
        Continuous variable (e.g., tumor size, biomarker level, age) for optimal 
        cut-point determination. The analysis will find the cut-point that maximizes 
        the separation in survival outcomes while controlling for multiple testing.

    - name: cutpointMethod
      title: 'Cut-point Method'
      type: List
      options:
        - title: "Maximal Selected Rank Statistics"
          name: maxstat
        - title: "Minimum p-value Approach"
          name: minpvalue
        - title: "Optimal Separation (survminer)"
          name: surv_cutpoint
        - title: "Multiple Methods Comparison"
          name: comprehensive
      default: maxstat
      description: >-
        Method for optimal cut-point determination. Maximal selected rank statistics 
        provides the most rigorous approach with proper multiple testing correction.

    - name: cutpointRange
      title: 'Cut-point Search Range'
      type: String
      default: "0.1, 0.9"
      description: >-
        Proportion range for cut-point search (e.g., "0.1, 0.9" excludes outer 
        10% to maintain statistical power). Prevents extreme cut-points that 
        create unbalanced groups.

    - name: multipleTestingCorrection
      title: 'Multiple Testing Correction'
      type: List
      options:
        - title: "Bonferroni"
          name: bonferroni
        - title: "Benjamini-Hochberg (FDR)"
          name: BH
        - title: "Holm"
          name: holm
        - title: "None"
          name: none
      default: bonferroni
      description: >-
        Multiple testing correction method for cut-point determination. 
        Bonferroni is most conservative; use when testing many cut-points.

    - name: validateCutpoint
      title: 'Cross-validate Cut-point'
      type: Bool
      default: false
      description: >-
        Perform cross-validation to assess stability of optimal cut-point. 
        Helps identify robust cut-points that are not dependent on specific 
        data characteristics.

    - name: cutpointBootstrap
      title: 'Bootstrap Cut-point Validation'
      type: Bool
      default: false
      description: >-
        Use bootstrap validation to assess cut-point stability and derive 
        confidence intervals. Provides robust assessment of cut-point reliability.

    - name: cutpointBootstrapReps
      title: 'Cut-point Bootstrap Repetitions'
      type: Number
      min: 100
      max: 1000
      default: 500
      description: >-
        Number of bootstrap repetitions for cut-point validation.

    - name: generateStagingSystem
      title: 'Generate New Staging System'
      type: Bool
      default: false
      description: >-
        Automatically generate a new staging system based on optimal cut-points. 
        Creates categorical staging variable from continuous measurements using 
        determined cut-points with appropriate stage labeling.

    - name: stagingSystemLevels
      title: 'Number of Staging Levels'
      type: Number
      min: 2
      max: 6
      default: 3
      description: >-
        Number of staging levels to create from optimal cut-points (e.g., 3 for 
        Low/Intermediate/High or 4 for Stages I-IV).

    # SHAP Model Interpretability Options
    - name: performSHAPAnalysis
      title: 'SHAP Model Interpretability'
      type: Bool
      default: false
      description: >-
        Perform Shapley Additive Explanations (SHAP) analysis to explain which 
        factors are driving the predictions of staging models. SHAP provides 
        both global feature importance and individual patient-level explanations 
        for complex staging decisions.

    - name: shapAnalysisType
      title: 'SHAP Analysis Type'
      type: List
      options:
        - title: "Global Feature Importance"
          name: global
        - title: "Individual Patient Explanations"
          name: individual
        - title: "Comprehensive Analysis"
          name: comprehensive
      default: comprehensive
      description: >-
        Type of SHAP analysis to perform. Global analysis shows overall feature 
        importance across all patients, individual analysis explains specific 
        patient predictions, comprehensive includes both approaches.

    - name: shapCovariates
      title: 'Variables for SHAP Analysis'
      type: Variables
      suggested: [continuous, ordinal, nominal]
      permitted: [numeric, factor]
      description: >-
        Additional variables to include in SHAP interpretability analysis 
        alongside staging variables. Include key clinical variables that 
        might influence staging decisions or patient outcomes.

    - name: shapSampleSize
      title: 'SHAP Sample Size'
      type: Number
      min: 50
      max: 1000
      default: 100
      description: >-
        Number of patients to use for SHAP analysis. Larger samples provide 
        more comprehensive explanations but require more computation time. 
        Recommended: 100-200 for routine analysis, 500+ for detailed research.

    - name: shapBackgroundSamples
      title: 'SHAP Background Samples'
      type: Number
      min: 10
      max: 500
      default: 50
      description: >-
        Number of background samples for SHAP baseline calculation. More 
        samples provide more stable explanations but increase computation time.

    - name: shapExplanationType
      title: 'SHAP Explanation Method'
      type: List
      options:
        - title: "TreeSHAP (for tree-based models)"
          name: tree
        - title: "Kernel SHAP (model-agnostic)"
          name: kernel
        - title: "Linear SHAP (for linear models)"
          name: linear
        - title: "Auto-detect best method"
          name: auto
      default: auto
      description: >-
        SHAP explanation method to use. Auto-detect chooses the most appropriate 
        method based on the model type. TreeSHAP is fastest for tree models, 
        Kernel SHAP works with any model but is slower.

    - name: generateSHAPPlots
      title: 'Generate SHAP Plots'
      type: Bool
      default: true
      description: >-
        Generate SHAP visualization plots including summary plots, bar plots, 
        and dependence plots for model interpretability.

    - name: shapPatientProfiles
      title: 'Patient Profile Examples'
      type: List
      options:
        - title: "High-risk patients"
          name: high_risk
        - title: "Low-risk patients"
          name: low_risk
        - title: "Representative patients"
          name: representative
        - title: "All profile types"
          name: all
      default: representative
      description: >-
        Types of patient profiles to include in individual SHAP explanations. 
        Helps understand how different patient characteristics influence 
        staging-based predictions.

    - name: shapInteractionAnalysis
      title: 'SHAP Interaction Analysis'
      type: Bool
      default: false
      description: >-
        Perform SHAP interaction analysis to identify important feature 
        interactions. Shows how combinations of features affect predictions 
        beyond individual feature effects.

    - name: shapClinicalThresholds
      title: 'Clinical Risk Thresholds'
      type: String
      default: "0.25, 0.50, 0.75"
      description: >-
        Comma-separated risk thresholds for clinical decision boundaries in 
        SHAP analysis (e.g., "0.25, 0.50, 0.75" for low/moderate/high risk). 
        Used to interpret SHAP values in clinical context.

    # Competing Risks Analysis with Fine-Gray Models Options
    - name: performCompetingRisksAdvanced
      title: 'Advanced Competing Risks Analysis'
      type: Bool
      default: false
      description: >-
        Perform comprehensive competing risks analysis using Fine-Gray 
        subdistribution hazard models and Cumulative Incidence Function (CIF) 
        analysis. Essential when competing events prevent observation of primary 
        outcome and standard survival analysis may be biased.

    - name: competingRisksMethod
      title: 'Competing Risks Method'
      type: List
      options:
        - title: "Fine-Gray Subdistribution Hazard"
          name: finegray
        - title: "Cause-Specific Hazard Models"
          name: causespecific
        - title: "Comprehensive Analysis (both methods)"
          name: comprehensive
      default: comprehensive
      description: >-
        Method for competing risks analysis. Fine-Gray models cumulative 
        incidence, cause-specific models instantaneous hazard rates. 
        Comprehensive includes both approaches for complete assessment.

    - name: cifTimePoints
      title: 'CIF Time Points (months)'
      type: String
      default: "12, 24, 36, 60"
      description: >-
        Time points for Cumulative Incidence Function analysis (e.g., 
        "12, 24, 36, 60" for 1, 2, 3, and 5-year analysis). Use clinically 
        relevant time points for the specific cancer type.

    - name: competingEventLevels
      title: 'Competing Event Categories'
      type: String
      default: "cancer_death, other_death, censored"
      description: >-
        Comma-separated list of event categories for competing risks analysis. 
        Typically includes primary event (cancer death), competing events 
        (other causes), and censoring indicator.

    - name: primaryEventLevel
      title: 'Primary Event of Interest'
      type: String
      default: "cancer_death"
      description: >-
        Specify the primary event of interest for competing risks analysis 
        (e.g., "cancer_death", "disease_progression", "cardiovascular_death"). 
        Must match one of the competing event categories.

    - name: generateCIFPlots
      title: 'Generate CIF Plots'
      type: Bool
      default: true
      description: >-
        Generate Cumulative Incidence Function plots showing probability of 
        each event type over time. Essential for visualizing competing risks 
        patterns and staging system comparisons.

    - name: performGrayTest
      title: 'Gray Test for CIF Equality'
      type: Bool
      default: true
      description: >-
        Perform Gray's test for equality of cumulative incidence functions 
        across staging groups. Tests whether CIF curves differ significantly 
        between stages for each event type.

    - name: cifConfidenceLevel
      title: 'CIF Confidence Level'
      type: Number
      min: 0.80
      max: 0.99
      default: 0.95
      description: >-
        Confidence level for Cumulative Incidence Function confidence intervals 
        and statistical tests.

    - name: competingRisksCovariates
      title: 'Competing Risks Covariates'
      type: Variables
      suggested: [continuous, ordinal, nominal]
      permitted: [numeric, factor]
      description: >-
        Additional variables to include in competing risks regression models. 
        Include important prognostic factors that may influence both primary 
        and competing events.

    - name: stratifyByStaging
      title: 'Stratify Analysis by Staging System'
      type: Bool
      default: true
      description: >-
        Perform separate competing risks analysis for each staging system 
        (original vs new) to compare their performance in the presence of 
        competing events.

    - name: calculateCRCIndex
      title: 'Competing Risks C-Index'
      type: Bool
      default: true
      description: >-
        Calculate C-index specifically adapted for competing risks analysis. 
        Provides discrimination metrics that properly account for competing 
        events when evaluating staging system performance.

    - name: generateCRSummary
      title: 'Competing Risks Summary Table'
      type: Bool
      default: true
      description: >-
        Generate comprehensive summary table with Fine-Gray regression results, 
        cumulative incidence estimates, and staging system comparisons in 
        competing risks context.

    # Multi-State Models for Complex Disease Transitions Options
    - name: performMultiStateAnalysis
      title: 'Multi-State Survival Models'
      type: Bool
      default: false
      description: >-
        Perform multi-state survival analysis for complex disease progression 
        scenarios where patients can transition between multiple health states 
        over time. Essential for modeling disease progression, remission, 
        relapse, and death in oncology.

    - name: multiStateModel
      title: 'Multi-State Model Type'
      type: List
      options:
        - title: "Illness-Death Model (3 states)"
          name: illness_death
        - title: "Progression Model (4 states)"
          name: progression
        - title: "Relapse-Death Model (4 states)"
          name: relapse_death
        - title: "Custom Model (user-defined)"
          name: custom
        - title: "Comprehensive Analysis (all models)"
          name: comprehensive
      default: illness_death
      description: >-
        Type of multi-state model to fit. Illness-Death models progression 
        from healthy to disease to death. Progression models include stable, 
        progressive, terminal states. Comprehensive fits multiple models for 
        comparison.

    - name: stateVariable
      title: 'Disease State Variable'
      type: Variable
      suggested:
        - nominal
        - ordinal
      permitted:
        - factor
        - numeric
      description: >-
        Variable indicating patient disease states (e.g., stable, progressive, 
        deceased, remission). Should contain all possible states that patients 
        can transition between during follow-up.

    - name: transitionTimeVariable
      title: 'Transition Time Variable'
      type: Variable
      suggested: [continuous]
      permitted: [numeric]
      description: >-
        Time variable indicating when state transitions occurred. For multiple 
        transitions per patient, use comma-separated times or separate records 
        for each transition.

    - name: multiStateStates
      title: 'State Definitions'
      type: String
      default: "healthy, disease, death"
      description: >-
        Comma-separated list of all possible states in order of progression 
        (e.g., "healthy, disease, death" or "stable, progressive, remission, death"). 
        Must match levels in the state variable.

    - name: absorptionStates
      title: 'Absorption States'
      type: String
      default: "death"
      description: >-
        Comma-separated list of absorbing states that patients cannot leave 
        once entered (e.g., "death", "terminal"). These represent final 
        outcomes in the disease process.

    - name: multiStateCovariates
      title: 'Multi-State Covariates'
      type: Variables
      suggested: [continuous, ordinal, nominal]
      permitted: [numeric, factor]
      description: >-
        Additional variables to include in multi-state models as covariates. 
        Include important prognostic factors that may influence transition 
        rates between states.

    - name: calculateTransitionProbabilities
      title: 'Calculate Transition Probabilities'
      type: Bool
      default: true
      description: >-
        Calculate state transition probabilities between all possible state 
        pairs. Provides insight into likelihood of disease progression, 
        remission, and mortality transitions.

    - name: multiStateTimePoints
      title: 'Multi-State Time Points (months)'
      type: String
      default: "6, 12, 24, 36, 60"
      description: >-
        Time points for transition probability calculations (e.g., 
        "6, 12, 24, 36, 60" for 6-month intervals up to 5 years). Use 
        clinically relevant time points for disease monitoring.

    - name: generateTransitionMatrix
      title: 'Generate Transition Matrix'
      type: Bool
      default: true
      description: >-
        Generate comprehensive transition intensity matrix showing hazard 
        rates for all possible state transitions. Essential for understanding 
        disease progression dynamics.

    - name: multiStateGraphics
      title: 'Multi-State Visualizations'
      type: Bool
      default: true
      description: >-
        Generate multi-state model visualizations including state transition 
        diagrams, probability plots, and Aalen-Johansen estimator curves for 
        state occupancy probabilities.

    - name: msStratifyByStaging
      title: 'Stratify by Staging System'
      type: Bool
      default: true
      description: >-
        Perform separate multi-state analysis for each staging system to 
        compare their ability to predict disease transitions and progression 
        patterns.

    - name: multiStateValidation
      title: 'Multi-State Model Validation'
      type: Bool
      default: false
      description: >-
        Perform model validation including goodness-of-fit testing, residual 
        analysis, and cross-validation for multi-state models. Computationally 
        intensive but provides robust model assessment.

    - name: generateMSMSummary
      title: 'Multi-State Summary Table'
      type: Bool
      default: true
      description: >-
        Generate comprehensive summary table with transition intensities, 
        hazard ratios, and state occupancy probabilities comparing staging 
        systems in multi-state framework.

    # Random Survival Forests for Non-Parametric Survival Modeling Options
    - name: performRandomForestAnalysis
      title: 'Random Survival Forests'
      type: Bool
      default: false
      description: >-
        Perform Random Survival Forest analysis as a non-parametric alternative 
        to Cox proportional hazards models. Provides robust predictions through 
        ensemble methods without proportional hazards assumptions, ideal for 
        complex interactions and non-linear relationships.

    - name: forestModelType
      title: 'Forest Model Type'
      type: List
      options:
        - title: "Random Survival Forest (RSF)"
          name: rsf
        - title: "Conditional Inference Forest"
          name: cforest
        - title: "Extremely Randomized Trees"
          name: extraTrees
        - title: "Ensemble Methods (all approaches)"
          name: ensemble
      default: rsf
      description: >-
        Type of random forest model to fit. RSF is the standard approach, 
        conditional inference forests handle categorical variables better, 
        extra trees provide additional randomization. Ensemble combines 
        multiple approaches for maximum robustness.

    - name: forestNTrees
      title: 'Number of Trees'
      type: Number
      min: 50
      max: 2000
      default: 500
      description: >-
        Number of trees in the random forest. More trees generally improve 
        performance but increase computation time. 500 trees provide good 
        balance between accuracy and speed for most applications.

    - name: forestMTry
      title: 'Variables per Split (mtry)'
      type: String
      default: "auto"
      description: >-
        Number of variables randomly selected at each split. Use "auto" for 
        automatic selection (sqrt of total variables), or specify a number. 
        Lower values increase randomization, higher values may improve accuracy.

    - name: forestMinNodeSize
      title: 'Minimum Node Size'
      type: Number
      min: 1
      max: 50
      default: 3
      description: >-
        Minimum number of observations in terminal nodes. Larger values prevent 
        overfitting but may reduce model flexibility. Recommended: 3-10 for 
        survival data depending on sample size.

    - name: forestCovariates
      title: 'Forest Covariates'
      type: Variables
      suggested: [continuous, ordinal, nominal]
      permitted: [numeric, factor]
      description: >-
        Additional variables to include in random forest models alongside 
        staging variables. Include important clinical variables for 
        comprehensive non-parametric survival modeling.

    - name: calculateVariableImportance
      title: 'Calculate Variable Importance'
      type: Bool
      default: true
      description: >-
        Calculate variable importance measures using permutation-based methods. 
        Shows which variables contribute most to survival predictions, 
        complementing SHAP analysis with forest-specific importance metrics.

    - name: forestImportanceType
      title: 'Importance Measure'
      type: List
      options:
        - title: "Permutation Importance"
          name: permutation
        - title: "Variable Hunting (VIMP)"
          name: vimp
        - title: "Minimal Depth"
          name: minimal_depth
        - title: "Comprehensive (all measures)"
          name: comprehensive
      default: permutation
      description: >-
        Type of variable importance measure. Permutation importance is most 
        interpretable, VIMP is RF-specific, minimal depth shows variable 
        selection frequency. Comprehensive provides all measures.

    - name: performForestValidation
      title: 'Forest Cross-Validation'
      type: Bool
      default: false
      description: >-
        Perform out-of-bag validation and cross-validation for random forest 
        models. Provides robust assessment of model performance including 
        prediction error rates and concordance indices.

    - name: forestPredictionTimePoints
      title: 'Prediction Time Points (months)'
      type: String
      default: "12, 24, 36, 60"
      description: >-
        Time points for survival probability predictions from random forest 
        models (e.g., "12, 24, 36, 60" for 1, 2, 3, and 5-year predictions). 
        Use clinically relevant time points for staging comparison.

    - name: generateSurvivalPredictions
      title: 'Generate Survival Predictions'
      type: Bool
      default: true
      description: >-
        Generate individual patient survival probability predictions at 
        specified time points. Provides personalized risk assessments 
        based on random forest ensemble predictions.

    - name: forestDiscriminationMetrics
      title: 'Forest Discrimination Analysis'
      type: Bool
      default: true
      description: >-
        Calculate discrimination metrics specifically for random forest models 
        including C-index, Integrated Brier Score, and time-dependent AUC. 
        Compares forest performance with traditional Cox models.

    - name: forestStagingComparison
      title: 'Forest-Based Staging Comparison'
      type: Bool
      default: true
      description: >-
        Use random forest models to compare staging systems through 
        non-parametric ensemble methods. Provides robust staging comparison 
        without proportional hazards assumptions.

    - name: forestBootstrap
      title: 'Bootstrap Forest Validation'
      type: Bool
      default: false
      description: >-
        Perform bootstrap validation of random forest models with multiple 
        bootstrap samples. Provides confidence intervals for forest-based 
        predictions and importance measures.

    - name: forestBootstrapSamples
      title: 'Bootstrap Samples'
      type: Number
      min: 50
      max: 500
      default: 100
      description: >-
        Number of bootstrap samples for forest validation. More samples 
        provide more stable confidence intervals but increase computation time.

    - name: generateForestSummary
      title: 'Forest Analysis Summary'
      type: Bool
      default: true
      description: >-
        Generate comprehensive summary of random forest analysis including 
        model performance, variable importance, staging comparison, and 
        clinical recommendations based on ensemble predictions.

    # ============================================================================
    # Cure Models for Populations with Cured Fraction
    # ============================================================================

    - name: performCureModelAnalysis
      title: 'Cure Models Analysis'
      type: Bool
      default: false
      description: >-
        Perform cure model analysis for populations where a fraction of patients 
        may be effectively cured. Uses mixture models to separate susceptible 
        and cured populations, particularly relevant for cancer staging analysis.

    - name: cureModelType
      title: 'Cure Model Type'
      type: List
      options:
        - name: mixture
          title: 'Mixture Cure Model'
        - name: promotion
          title: 'Promotion Time Model'
        - name: both
          title: 'Both Model Types'
      default: mixture
      description: >-
        Type of cure model to fit. Mixture models assume a cured fraction with 
        infinite survival, promotion time models use biological mechanisms, 
        and both provides comprehensive comparison.

    - name: cureDistribution
      title: 'Survival Distribution'
      type: List
      options:
        - name: weibull
          title: 'Weibull'
        - name: exponential
          title: 'Exponential'
        - name: lognormal
          title: 'Log-Normal'
        - name: loglogistic
          title: 'Log-Logistic'
      default: weibull
      description: >-
        Underlying survival distribution for the susceptible population in 
        cure models. Weibull is most flexible, exponential is simplest, 
        log-normal and log-logistic provide alternative hazard shapes.

    - name: cureAnalyzeOldStage
      title: 'Analyze Original Staging'
      type: Bool
      default: true
      description: >-
        Fit cure models to original staging system to estimate cure fractions 
        and survival patterns for susceptible patients in each stage.

    - name: cureAnalyzeNewStage
      title: 'Analyze New Staging'
      type: Bool
      default: true
      description: >-
        Fit cure models to new staging system to estimate cure fractions and 
        survival patterns, enabling comparison of staging discrimination for 
        both cured and susceptible populations.

    - name: cureFractionEstimation
      title: 'Cure Fraction Method'
      type: List
      options:
        - name: parametric
          title: 'Parametric Estimation'
        - name: nonparametric
          title: 'Non-parametric (Kaplan-Meier)'
        - name: both
          title: 'Both Methods'
      default: parametric
      description: >-
        Method for estimating cure fractions. Parametric uses maximum likelihood 
        with specified distributions, non-parametric uses Kaplan-Meier plateau 
        detection, both provides validation.

    - name: cureConfidenceLevel
      title: 'Confidence Level'
      type: Number
      min: 0.80
      max: 0.99
      default: 0.95
      description: >-
        Confidence level for cure model parameter estimates and cure fraction 
        confidence intervals. Standard 95% provides balance between precision 
        and coverage.

    - name: cureBootstrapCI
      title: 'Bootstrap Confidence Intervals'
      type: Bool
      default: true
      description: >-
        Calculate bootstrap confidence intervals for cure fractions and model 
        parameters. Provides robust uncertainty quantification especially for 
        small samples or complex models.

    - name: cureBootstrapReps
      title: 'Bootstrap Replications'
      type: Number
      min: 100
      max: 2000
      default: 500
      description: >-
        Number of bootstrap replications for confidence interval calculation. 
        More replications provide more stable intervals but increase 
        computation time.

    - name: cureTimeHorizon
      title: 'Cure Assessment Time (months)'
      type: Number
      min: 12
      max: 240
      default: 120
      description: >-
        Time horizon for cure assessment in months. Patients surviving beyond 
        this time without events are considered potentially cured. Typical 
        values: 60-120 months for most cancers.

    - name: curePlateauThreshold
      title: 'Plateau Detection Threshold'
      type: Number
      min: 0.01
      max: 0.10
      default: 0.05
      description: >-
        Threshold for detecting survival curve plateau in non-parametric cure 
        fraction estimation. Lower values detect smaller plateaus but may be 
        more sensitive to noise.

    - name: cureCovariates
      title: 'Cure Model Covariates'
      type: Variables
      suggested: [continuous, ordinal, nominal]
      permitted: [numeric, factor]
      description: >-
        Additional variables to include in cure model analysis alongside staging 
        variables. Can affect both cure probability and survival of susceptible 
        patients.

    - name: cureModelComparison
      title: 'Model Comparison Analysis'
      type: Bool
      default: true
      description: >-
        Compare cure models between staging systems using likelihood ratio tests, 
        AIC/BIC criteria, and cure fraction differences. Assesses which staging 
        system better identifies cured patients.

    - name: cureStageSpecificAnalysis
      title: 'Stage-Specific Cure Analysis'
      type: Bool
      default: true
      description: >-
        Perform separate cure model analysis for each stage group to understand 
        stage-specific cure patterns and survival of susceptible patients. 
        Essential for staging validation.

    - name: cureGoodnessOfFit
      title: 'Goodness-of-Fit Testing'
      type: Bool
      default: true
      description: >-
        Perform goodness-of-fit tests for cure models including Kolmogorov-Smirnov 
        tests and visual diagnostic plots. Validates model assumptions and 
        identifies potential misspecification.

    - name: generateCureSummary
      title: 'Cure Model Summary'
      type: Bool
      default: true
      description: >-
        Generate comprehensive summary of cure model analysis including cure 
        fractions by stage, model comparison results, and clinical interpretation 
        for staging system evaluation.

    - name: performIntervalCensoringAnalysis
      title: 'Interval Censoring Analysis'
      type: Bool
      default: false
      description:
        R: >
          Perform interval censoring analysis for events detected between visits.
          This handles cases where the exact event time is unknown but falls 
          within a known interval (e.g., between clinic visits). Uses icenReg 
          package for non-parametric and parametric interval-censored survival 
          analysis.

    - name: intervalCensoringLeftTime
      title: 'Left Interval Time Variable'
      type: Variable
      suggested:
        - continuous
      permitted:
        - numeric
      description:
        R: >
          Variable containing the left endpoint of the censoring interval.
          For exact observations, this should equal the right endpoint.
          For left-censored observations, use 0 or NA.

    - name: intervalCensoringRightTime
      title: 'Right Interval Time Variable'  
      type: Variable
      suggested:
        - continuous
      permitted:
        - numeric
      description:
        R: >
          Variable containing the right endpoint of the censoring interval.
          For right-censored observations, use Inf or a large value.
          For exact observations, this should equal the left endpoint.

    - name: intervalCensoringDistribution
      title: 'Distribution for Parametric Model'
      type: List
      options:
        - name: weibull
          title: 'Weibull'
        - name: loglogistic
          title: 'Log-logistic'  
        - name: lognormal
          title: 'Log-normal'
        - name: exponential
          title: 'Exponential'
        - name: gamma
          title: 'Gamma'
      default: weibull
      description:
        R: >
          Distribution assumption for parametric interval-censored regression.
          Weibull is most commonly used and provides good flexibility.

    - name: intervalCensoringModel
      title: 'Model Type'
      type: List
      options:
        - name: nonparametric
          title: 'Non-parametric (NPMLE)'
        - name: parametric
          title: 'Parametric Regression'
        - name: both
          title: 'Both Models'
      default: both
      description:
        R: >
          Type of interval censoring model to fit. Non-parametric uses
          non-parametric maximum likelihood estimation (NPMLE). Parametric
          fits accelerated failure time models with specified distribution.

    - name: intervalCensoringBootstrap
      title: 'Bootstrap Confidence Intervals'
      type: Bool
      default: true
      description:
        R: >
          Calculate bootstrap confidence intervals for non-parametric estimates.
          This provides uncertainty quantification for the survival function
          estimates with interval-censored data.

    - name: intervalCensoringBootstrapSamples
      title: 'Bootstrap Samples'
      type: Integer
      default: 1000
      min: 100
      max: 10000
      description:
        R: >
          Number of bootstrap samples for confidence interval calculation.
          More samples provide more accurate intervals but increase computation time.

    - name: intervalCensoringCompareStages
      title: 'Compare Staging Systems'
      type: Bool
      default: true
      description:
        R: >
          Compare survival functions between different staging systems
          accounting for interval censoring. Provides likelihood ratio tests
          and information criteria for model comparison.

    - name: intervalCensoringPlots
      title: 'Generate Survival Plots'
      type: Bool
      default: true
      description:
        R: >
          Generate survival plots specifically designed for interval-censored data,
          including non-parametric survival function estimates and comparison
          plots between staging systems.

    - name: intervalCensoringDiagnostics
      title: 'Model Diagnostics'
      type: Bool
      default: true
      description:
        R: >
          Perform model diagnostics including convergence assessment,
          residual analysis for parametric models, and goodness-of-fit tests
          for interval-censored regression models.

    - name: intervalCensoringPredictionTime
      title: 'Prediction Time Points'
      type: String
      default: '12, 24, 36, 60'
      description:
        R: >
          Comma-separated list of time points (in months) for survival probability
          predictions. These will be used for staging system comparison and
          clinical interpretation of interval-censored survival estimates.

    - name: intervalCensoringConfidenceLevel
      title: 'Confidence Level'
      type: Number
      default: 0.95
      min: 0.8
      max: 0.99
      description:
        R: >
          Confidence level for interval estimates and hypothesis tests.
          Standard choices are 0.90, 0.95, or 0.99.

    - name: intervalCensoringAdjustVariables
      title: 'Adjustment Variables'
      type: Variables
      suggested:
        - continuous
        - nominal
        - ordinal
      permitted:
        - numeric
        - factor
      description:
        R: >
          Additional variables to include in parametric interval-censored regression
          models for adjusted survival analysis. These will be included as covariates
          in the accelerated failure time model.

    - name: performInformativeCensoringAnalysis
      title: 'Informative Censoring Detection'
      type: Bool
      default: false
      description:
        R: >
          Perform tests for informative censoring to validate the assumption that
          censoring is non-informative. Informative censoring occurs when the
          censoring mechanism is related to the failure time, potentially biasing
          survival estimates. This analysis provides tests and adjustments for
          non-random censoring patterns.

    - name: informativeCensoringTestMethod
      title: 'Test Method for Informative Censoring'
      type: List
      options:
        - name: all_tests
          title: 'All Available Tests'
        - name: correlation_test
          title: 'Correlation Test'
        - name: regression_test
          title: 'Regression-Based Test'
        - name: competing_risks
          title: 'Competing Risks Approach'
        - name: landmark_analysis
          title: 'Landmark Analysis'
      default: all_tests
      description:
        R: >
          Method for testing informative censoring. Correlation tests examine
          relationship between censoring and survival times. Regression tests
          model censoring as outcome. Competing risks treats censoring as
          competing event. Landmark analysis examines censoring patterns.

    - name: informativeCensoringCovariates
      title: 'Censoring Mechanism Covariates'
      type: Variables
      suggested:
        - continuous
        - nominal
        - ordinal
      permitted:
        - numeric
        - factor
      description:
        R: >
          Variables that may be associated with the censoring mechanism.
          These could include clinical factors, treatment decisions, or
          administrative factors that might influence when patients are
          censored from the study.

    - name: informativeCensoringLandmarkTimes
      title: 'Landmark Time Points'
      type: String
      default: '12, 24, 36, 60'
      description:
        R: >
          Comma-separated list of landmark time points (in months) for
          landmark analysis of censoring patterns. Analysis examines
          whether censoring probabilities differ across staging groups
          at these specific time points.

    - name: informativeCensoringAdjustmentMethod
      title: 'Adjustment Method'
      type: List
      options:
        - name: none
          title: 'No Adjustment'
        - name: ipw
          title: 'Inverse Probability Weighting'
        - name: multiple_imputation
          title: 'Multiple Imputation'
        - name: sensitivity_analysis
          title: 'Sensitivity Analysis'
      default: sensitivity_analysis
      description:
        R: >
          Method for adjusting survival estimates when informative censoring
          is detected. IPW uses inverse probability weighting. Multiple
          imputation imputes censored failure times. Sensitivity analysis
          explores range of possible bias effects.

    - name: informativeCensoringIPWVariables
      title: 'IPW Model Variables'
      type: Variables
      suggested:
        - continuous
        - nominal
        - ordinal
      permitted:
        - numeric
        - factor
      description:
        R: >
          Variables to include in inverse probability weighting model for
          censoring probability estimation. Should include factors that
          predict censoring but are not affected by the outcome.

    - name: informativeCensoringSensitivityRange
      title: 'Sensitivity Analysis Range'
      type: String
      default: '0.8, 0.9, 1.0, 1.1, 1.2'
      description:
        R: >
          Comma-separated list of sensitivity parameters for bias analysis.
          These represent hazard ratio multipliers for exploring potential
          bias from informative censoring (1.0 = no bias assumption).

    - name: informativeCensoringBootstrap
      title: 'Bootstrap Confidence Intervals'
      type: Bool
      default: true
      description:
        R: >
          Calculate bootstrap confidence intervals for adjusted survival
          estimates and bias-corrected parameters. Provides uncertainty
          quantification for informative censoring adjustments.

    - name: informativeCensoringBootstrapSamples
      title: 'Bootstrap Samples'
      type: Integer
      default: 1000
      min: 100
      max: 5000
      description:
        R: >
          Number of bootstrap samples for confidence interval calculation
          in informative censoring analysis. More samples provide more
          accurate intervals but increase computation time.

    - name: informativeCensoringAlpha
      title: 'Significance Level'
      type: Number
      default: 0.05
      min: 0.01
      max: 0.10
      description:
        R: >
          Significance level for testing informative censoring hypotheses.
          Used for determining whether censoring appears to be informative
          and for confidence interval construction.

    - name: informativeCensoringPlots
      title: 'Generate Diagnostic Plots'
      type: Bool
      default: true
      description:
        R: >
          Generate diagnostic plots for informative censoring assessment
          including censoring probability over time, correlation plots,
          and sensitivity analysis visualizations.

    - name: informativeCensoringCompareStages
      title: 'Compare Censoring Across Stages'
      type: Bool
      default: true
      description:
        R: >
          Compare censoring patterns across different staging groups to
          assess whether censoring differs by stage, which could indicate
          stage-related informative censoring that affects staging
          system evaluation.

    - name: performConcordanceProbabilityAnalysis
      title: 'Concordance Probability Analysis'
      type: Bool
      default: false
      description:
        R: >
          Perform advanced concordance probability analysis for heavily censored data.
          This provides alternative concordance measures beyond traditional C-index,
          including Harrell's C-index modifications, Uno's C-index for heavily censored
          data, and time-dependent concordance measures specifically designed for
          staging system evaluation with high censoring rates.

    - name: concordanceProbabilityMethods
      title: 'Concordance Methods'
      type: List
      options:
        - name: all_methods
          title: 'All Available Methods'
        - name: harrell_c
          title: 'Harrell C-index'
        - name: uno_c
          title: 'Uno C-index'
        - name: time_dependent
          title: 'Time-Dependent Concordance'
        - name: ipcw_concordance
          title: 'IPCW Concordance'
        - name: weighted_concordance
          title: 'Weighted Concordance'
      default: all_methods
      description:
        R: >
          Concordance probability estimation methods. Harrell C-index is traditional
          but may be biased with heavy censoring. Uno C-index uses inverse probability
          weighting for censoring. Time-dependent measures evaluate concordance at
          specific time points. IPCW and weighted methods provide robust alternatives.

    - name: concordanceProbabilityTimePoints
      title: 'Time Points for Assessment'
      type: String
      default: '12, 24, 36, 60, 120'
      description:
        R: >
          Comma-separated list of time points (in months) for time-dependent
          concordance assessment. These will be used for evaluating staging
          system discrimination at clinically relevant time horizons.

    - name: concordanceProbabilityWeighting
      title: 'Weighting Strategy'
      type: List
      options:
        - name: uniform
          title: 'Uniform Weighting'
        - name: sample_size
          title: 'Sample Size Weighting'
        - name: event_rate
          title: 'Event Rate Weighting'
        - name: follow_up
          title: 'Follow-up Time Weighting'
        - name: inverse_variance
          title: 'Inverse Variance Weighting'
      default: uniform
      description:
        R: >
          Weighting strategy for concordance probability estimation.
          Uniform gives equal weight to all pairs. Sample size weights by
          stage frequency. Event rate weights by observed events. Follow-up
          weights by observation time. Inverse variance uses precision weighting.

    - name: concordanceProbabilityBootstrap
      title: 'Bootstrap Confidence Intervals'
      type: Bool
      default: true
      description:
        R: >
          Calculate bootstrap confidence intervals for concordance probability
          estimates. This provides uncertainty quantification for discrimination
          measures, especially important for heavily censored data where
          traditional standard errors may be unreliable.

    - name: concordanceProbabilityBootstrapSamples
      title: 'Bootstrap Samples'
      type: Integer
      default: 1000
      min: 100
      max: 5000
      description:
        R: >
          Number of bootstrap samples for confidence interval calculation.
          More samples provide more accurate intervals but increase computation
          time. Recommended minimum 500 for reliable confidence intervals.

    - name: concordanceProbabilityConfidenceLevel
      title: 'Confidence Level'
      type: Number
      default: 0.95
      min: 0.8
      max: 0.99
      description:
        R: >
          Confidence level for concordance probability confidence intervals.
          Standard choices are 0.90, 0.95, or 0.99 for 90%, 95%, or 99%
          confidence intervals respectively.

    - name: concordanceProbabilityCompareStages
      title: 'Compare Staging Systems'
      type: Bool
      default: true
      description:
        R: >
          Compare concordance probabilities between different staging systems
          using hypothesis tests and confidence interval overlap assessment.
          Provides statistical evidence for staging system discrimination
          differences accounting for heavy censoring.

    - name: concordanceProbabilityAdjustVariables
      title: 'Adjustment Variables'
      type: Variables
      suggested:
        - continuous
        - nominal
        - ordinal
      permitted:
        - numeric
        - factor
      description:
        R: >
          Additional variables to include in adjusted concordance analysis.
          These variables will be included alongside staging in multivariable
          models to assess staging contribution to discrimination beyond
          other prognostic factors.

    - name: concordanceProbabilityRobustnessAnalysis
      title: 'Robustness Analysis'
      type: Bool
      default: true
      description:
        R: >
          Perform robustness analysis for concordance probability estimates
          including sensitivity to censoring assumptions, outlier influence,
          and temporal stability assessment for comprehensive validation
          of staging system discrimination.

    - name: concordanceProbabilityAlpha
      title: 'Significance Level'
      type: Number
      default: 0.05
      min: 0.01
      max: 0.10
      description:
        R: >
          Significance level for concordance probability hypothesis tests
          and confidence interval construction. Used for testing differences
          between staging systems and assessing statistical significance
          of discrimination improvements.

    - name: concordanceProbabilityDiagnostics
      title: 'Diagnostic Assessment'
      type: Bool
      default: true
      description:
        R: >
          Perform diagnostic assessment of concordance probability estimates
          including convergence checks, influence diagnostics, and
          sensitivity analysis to ensure reliable discrimination assessment
          for staging system evaluation.

    - name: performWinRatioAnalysis
      title: 'Win Ratio Analysis'
      type: Bool
      default: false
      description:
        R: >
          Perform win ratio analysis for composite endpoint analysis in staging
          comparison. The win ratio is a novel method for analyzing composite
          endpoints that respects the clinical hierarchy of outcomes and provides
          intuitive interpretation for staging system evaluation.

    - name: winRatioEndpoints
      title: 'Endpoint Hierarchy'
      type: List
      options:
        - name: death_progression_response
          title: 'Death > Disease Progression > Response'
        - name: death_recurrence_remission
          title: 'Death > Recurrence > Remission'
        - name: death_hospitalization_qol
          title: 'Death > Hospitalization > Quality of Life'
        - name: custom
          title: 'Custom Hierarchy'
      default: death_progression_response
      description:
        R: >
          Clinical hierarchy of endpoints for win ratio analysis. More important
          outcomes are prioritized in the analysis. Death is typically the most
          important endpoint, followed by disease-specific outcomes. The hierarchy
          determines how patient pairs are compared.

    - name: winRatioDeathVariable
      title: 'Death/Primary Endpoint Variable'
      type: Variable
      suggested:
        - nominal
      permitted:
        - numeric
        - factor
      description:
        R: >
          Variable indicating death or primary endpoint occurrence (1 = event, 0 = no event).
          This is typically the most important outcome in the hierarchy and is
          compared first when evaluating patient pairs.

    - name: winRatioSecondaryEndpoint
      title: 'Secondary Endpoint Variable'
      type: Variable
      suggested:
        - nominal
        - continuous
      permitted:
        - numeric
        - factor
      description:
        R: >
          Variable for secondary endpoint (e.g., disease progression, recurrence).
          This endpoint is evaluated when the primary endpoint comparison is tied.
          Can be binary (event/no event) or continuous (time to event).

    - name: winRatioTertiaryEndpoint
      title: 'Tertiary Endpoint Variable'
      type: Variable
      suggested:
        - nominal
        - continuous
      permitted:
        - numeric
        - factor
      description:
        R: >
          Variable for tertiary endpoint (e.g., response, quality of life).
          This endpoint is evaluated when both primary and secondary comparisons
          are tied. Can be binary or continuous.

    - name: winRatioTimeVariables
      title: 'Time Variables for Endpoints'
      type: Variables
      suggested:
        - continuous
      permitted:
        - numeric
      description:
        R: >
          Time variables corresponding to each endpoint in the hierarchy.
          Should be provided in the same order as the endpoints. Used for
          time-to-event comparisons when endpoints are not binary.

    - name: winRatioMatchingStrategy
      title: 'Matching Strategy'
      type: List
      options:
        - name: all_pairs
          title: 'All Possible Pairs'
        - name: matched_pairs
          title: 'Matched Pairs Only'
        - name: stratified
          title: 'Stratified by Stage'
        - name: propensity_matched
          title: 'Propensity Score Matched'
      default: all_pairs
      description:
        R: >
          Strategy for forming patient pairs for comparison. All pairs compares
          every patient from one group with every patient from another. Matched
          pairs uses pre-specified matching. Stratified performs within-stage
          comparisons. Propensity matching balances baseline characteristics.

    - name: winRatioConfidenceMethod
      title: 'Confidence Interval Method'
      type: List
      options:
        - name: bootstrap
          title: 'Bootstrap'
        - name: asymptotic
          title: 'Asymptotic'
        - name: permutation
          title: 'Permutation'
      default: bootstrap
      description:
        R: >
          Method for calculating confidence intervals for the win ratio.
          Bootstrap is most robust but computationally intensive. Asymptotic
          uses large sample theory. Permutation provides exact p-values.

    - name: winRatioBootstrapSamples
      title: 'Bootstrap Samples'
      type: Integer
      default: 1000
      min: 100
      max: 5000
      description:
        R: >
          Number of bootstrap samples for confidence interval calculation
          when using bootstrap method. More samples provide more accurate
          intervals but increase computation time.

    - name: winRatioConfidenceLevel
      title: 'Confidence Level'
      type: Number
      default: 0.95
      min: 0.8
      max: 0.99
      description:
        R: >
          Confidence level for win ratio confidence intervals and hypothesis
          tests. Standard choices are 0.90, 0.95, or 0.99 for 90%, 95%, or
          99% confidence intervals respectively.

    - name: winRatioHandleTies
      title: 'Tie Handling Strategy'
      type: List
      options:
        - name: split
          title: 'Split Ties (0.5 each)'
        - name: ignore
          title: 'Ignore Tied Pairs'
        - name: next_endpoint
          title: 'Use Next Endpoint'
      default: next_endpoint
      description:
        R: >
          Strategy for handling tied comparisons. Split assigns 0.5 wins to each.
          Ignore excludes tied pairs from analysis. Next endpoint proceeds to
          compare the next outcome in the hierarchy for tied pairs.

    - name: winRatioSensitivityAnalysis
      title: 'Sensitivity Analysis'
      type: Bool
      default: true
      description:
        R: >
          Perform sensitivity analysis for win ratio including assessment of
          endpoint ordering impact, missing data influence, and robustness
          to matching strategy choices.

    - name: winRatioGeneralizedPairwise
      title: 'Generalized Pairwise Comparison'
      type: Bool
      default: false
      description:
        R: >
          Use generalized pairwise comparison (GPC) framework which extends
          win ratio to include continuous outcomes and provides additional
          metrics like net benefit and win odds.

    # Frailty Models for Clustering Analysis
    - name: performFrailtyModelsAnalysis
      title: 'Frailty Models Analysis'
      type: Bool
      default: false
      description:
        R: >
          Perform frailty models analysis for clustered survival data using 
          mixed-effects Cox models (coxme) for multi-institutional data with 
          center-specific random effects and clustering adjustments.

    - name: frailtyClusterVariable
      title: 'Cluster Variable'
      type: Variable
      suggested:
        - nominal
        - ordinal
      description:
        R: >
          Variable defining clusters/institutions for frailty modeling (e.g., 
          hospital, center, surgeon). Used to account for unobserved 
          heterogeneity and clustering effects in survival analysis.

    - name: frailtyDistribution
      title: 'Frailty Distribution'
      type: List
      options:
        - name: gamma
          title: 'Gamma Distribution'
        - name: gaussian
          title: 'Gaussian (Normal) Distribution'
        - name: log-normal
          title: 'Log-Normal Distribution'
      default: gamma
      description:
        R: >
          Distribution assumption for the frailty (random effects) terms.
          Gamma distribution is most common and provides multiplicative 
          frailty effects on the hazard function.

    - name: frailtyBootstrap
      title: 'Bootstrap Validation'
      type: Bool
      default: true
      description:
        R: >
          Perform bootstrap validation for frailty model parameters and 
          variance components to assess model stability and provide 
          robust confidence intervals.

    - name: frailtyBootstrapSamples
      title: 'Bootstrap Samples'
      type: Integer
      min: 100
      max: 2000
      default: 500
      description:
        R: >
          Number of bootstrap samples for frailty model validation. 
          Higher values provide more stable estimates but increase 
          computational time.

    - name: frailtyVarianceComponents
      title: 'Variance Components Analysis'
      type: Bool
      default: true
      description:
        R: >
          Analyze variance components to quantify the proportion of 
          total variation explained by cluster-level random effects 
          vs individual-level factors.

    - name: frailtyHeterogeneityTest
      title: 'Heterogeneity Testing'
      type: Bool
      default: true
      description:
        R: >
          Test for significant frailty/heterogeneity using likelihood 
          ratio tests comparing frailty models to standard Cox models 
          without random effects.

    - name: frailtyClusterComparison
      title: 'Cluster-Specific Analysis'
      type: Bool
      default: false
      description:
        R: >
          Perform cluster-specific survival analysis comparing staging 
          systems within each cluster/institution to assess consistency 
          of staging performance across centers.

    - name: frailtyModelSelection
      title: 'Model Selection'
      type: Bool
      default: true
      description:
        R: >
          Perform systematic model selection comparing different frailty 
          distributions and model specifications using AIC/BIC criteria 
          and likelihood ratio tests.

    - name: frailtyPredictiveAccuracy
      title: 'Predictive Accuracy Assessment'
      type: Bool
      default: false
      description:
        R: >
          Assess predictive accuracy of frailty models using cross-validation 
          and concordance measures accounting for clustering structure in 
          the data.

    - name: frailtyDiagnostics
      title: 'Model Diagnostics'
      type: Bool
      default: true
      description:
        R: >
          Comprehensive model diagnostics including residual analysis, 
          influence detection, and goodness-of-fit assessment for frailty 
          models with clustering adjustments.

    - name: frailtyAdvancedInference
      title: 'Advanced Statistical Inference'
      type: Bool
      default: false
      description:
        R: >
          Advanced statistical inference including profile likelihood 
          confidence intervals, score tests, and robust variance 
          estimation for complex frailty model specifications.

    # Clinical Utility Index Analysis
    - name: performClinicalUtilityAnalysis
      title: 'Clinical Utility Index Analysis'
      type: Bool
      default: false
      description:
        R: >
          Perform clinical utility index analysis combining sensitivity/specificity 
          with disease prevalence to assess clinical decision-making value of 
          staging systems beyond statistical discrimination.

    - name: clinicalUtilityPrevalence
      title: 'Disease Prevalence'
      type: Number
      min: 0.01
      max: 0.99
      default: 0.2
      description:
        R: >
          Disease prevalence (proportion with events) for clinical utility 
          calculations. Can be estimated from study data or specified based 
          on population characteristics.

    - name: clinicalUtilityTimePoint
      title: 'Time Point for Analysis (months)'
      type: Integer
      min: 1
      max: 240
      default: 60
      description:
        R: >
          Time point (in months) for clinical utility assessment. Should 
          represent clinically relevant decision-making horizon for the 
          specific cancer type and staging system.

    - name: clinicalUtilityThresholds
      title: 'Risk Threshold Range'
      type: List
      options:
        - name: conservative
          title: 'Conservative (5-25%)'
        - name: standard
          title: 'Standard (10-50%)'
        - name: aggressive
          title: 'Aggressive (15-75%)'
        - name: comprehensive
          title: 'Comprehensive (5-95%)'
      default: standard
      description:
        R: >
          Range of risk thresholds for clinical utility assessment. Different 
          ranges appropriate for different clinical decision contexts and 
          treatment aggressiveness preferences.

    - name: clinicalUtilityNNT
      title: 'Number Needed to Treat Analysis'
      type: Bool
      default: true
      description:
        R: >
          Calculate Number Needed to Treat (NNT) and Number Needed to Harm (NNH) 
          based on staging-guided interventions with configurable treatment 
          effect assumptions.

    - name: clinicalUtilityTreatmentEffect
      title: 'Treatment Effect (Hazard Ratio)'
      type: Number
      min: 0.1
      max: 2.0
      default: 0.7
      description:
        R: >
          Assumed treatment effect (hazard ratio) for calculating NNT/NNH. 
          Should reflect realistic treatment benefits for staging-guided 
          interventions in the specific clinical context.

    - name: clinicalUtilityComparison
      title: 'Comparative Utility Assessment'
      type: Bool
      default: true
      description:
        R: >
          Compare clinical utility between staging systems using net benefit 
          difference analysis and utility improvement quantification across 
          different risk thresholds.

    - name: clinicalUtilityCostEffectiveness
      title: 'Cost-Effectiveness Integration'
      type: Bool
      default: false
      description:
        R: >
          Include basic cost-effectiveness considerations in clinical utility 
          assessment with configurable cost assumptions for staging-guided 
          interventions and outcomes.

    - name: clinicalUtilityCostPerIntervention
      title: 'Cost Per Intervention ($)'
      type: Integer
      min: 100
      max: 100000
      default: 5000
      description:
        R: >
          Estimated cost per staging-guided intervention for cost-effectiveness 
          analysis. Should reflect realistic healthcare costs in the relevant 
          healthcare system and setting.

    - name: clinicalUtilityBootstrap
      title: 'Bootstrap Validation'
      type: Bool
      default: true
      description:
        R: >
          Perform bootstrap validation for clinical utility metrics including 
          confidence intervals for NNT, net benefit differences, and utility 
          improvement measures.

    - name: clinicalUtilityBootstrapSamples
      title: 'Bootstrap Samples'
      type: Integer
      min: 100
      max: 2000
      default: 500
      description:
        R: >
          Number of bootstrap samples for clinical utility validation. Higher 
          values provide more stable estimates but increase computational time.

    - name: clinicalUtilityTimeVarying
      title: 'Time-Varying Utility Analysis'
      type: Bool
      default: false
      description:
        R: >
          Assess clinical utility across multiple time points to understand 
          how staging system value changes over time horizon and identify 
          optimal decision timing.


...
